Today: 14 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Bank of America (BAC) stock slides after earnings as Wall Street parses interest income outlook

Bank of America (BAC) stock slides after earnings as Wall Street parses interest income outlook

Bank of America shares fell 4% to $52.37 after fourth-quarter earnings, despite net income rising to $7.6 billion and net interest income jumping 10% to $15.8 billion. Investors focused on 2026 lending and margin forecasts as major U.S. bank stocks slipped. The bank set aside $1.3 billion for credit losses. Markets await the Federal Reserve’s late-January policy meeting for signals on interest rates.
14 January 2026
Adobe stock slides again as fresh downgrade, Apple’s new Creator Studio sharpen AI competition fears

Adobe stock slides again as fresh downgrade, Apple’s new Creator Studio sharpen AI competition fears

Adobe shares fell about 1.7% midday Wednesday after Oppenheimer downgraded the stock, citing concerns that generative AI could pressure pricing and slow subscriber growth. Apple announced its new Creator Studio app bundle will launch Jan. 28 at $12.99 per month, intensifying competition in the creative software market.
AppLovin stock dives 10% in New York trade even as Evercore, Morgan Stanley flag upside

AppLovin stock dives 10% in New York trade even as Evercore, Morgan Stanley flag upside

AppLovin shares plunged 10.1% to $601.05 Wednesday, outpacing the Nasdaq’s decline, after opening higher than Tuesday’s close. Evercore ISI began coverage with an Outperform rating and $835 target, while Morgan Stanley raised its target to $800. The company’s next earnings report is set for Feb. 11. The SEC continues to investigate AppLovin’s data-collection practices, with no charges filed.
14 January 2026
Eli Lilly stock slips as FDA drops suicide warning for Zepbound; traders eye orforglipron, earnings next

Eli Lilly stock slips as FDA drops suicide warning for Zepbound; traders eye orforglipron, earnings next

Eli Lilly shares fell about 0.4% Wednesday after the FDA ordered drugmakers to remove suicidality warnings from obesity drugs including Zepbound. The FDA said its review found no increased risk of suicidal thoughts with GLP-1 drugs. Investors are watching for updates on Lilly’s oral obesity pill ahead of the Feb. 4 earnings call.
Robinhood Markets (HOOD) stock slips as CME’s silver futures plan spotlights its push into derivatives

Robinhood Markets (HOOD) stock slips as CME’s silver futures plan spotlights its push into derivatives

Robinhood Markets shares fell 1.5% to $118.40 by late morning Wednesday amid a broader Wall Street decline. CME Group said it will launch a 100-ounce silver futures contract on Feb. 9, pending review, with Robinhood planning to offer access. Coinbase rose 3.3% as bitcoin climbed 4.2% to $97,383. U.S. core CPI rose 2.6% year-on-year in December, below forecasts, sending gold and silver to record highs.
Johnson & Johnson stock rises on Auris court win as talc fight and Jan. 21 earnings loom

Johnson & Johnson stock rises on Auris court win as talc fight and Jan. 21 earnings loom

Johnson & Johnson shares rose 1.9% to $217.80 by late morning Wednesday, outperforming a 1% drop in the S&P 500. Delaware’s Supreme Court threw out part of a ruling tied to Auris Health merger payments, possibly cutting damages by hundreds of millions. Legal battles over talc litigation continue. J&J’s Q4 earnings call is scheduled for Jan. 21.
Salesforce stock slips in regular trade as AI worries linger despite Slackbot rollout

Salesforce stock slips in regular trade as AI worries linger despite Slackbot rollout

Salesforce shares fell 0.6% to $239.72 Wednesday, extending a 6.5% drop from the previous session, its steepest since May 2024. The decline followed investor doubts over near-term revenue from new AI features, including the Slackbot rollout. The broader software sector and Dow also slipped. Salesforce’s new Slackbot is now available to Business+ and Enterprise+ customers.
Walmart stock slips as Nasdaq-100 debut nears and Google Gemini shopping deal draws focus

Walmart stock slips as Nasdaq-100 debut nears and Google Gemini shopping deal draws focus

Walmart shares fell about 1% to $119.17 Wednesday morning, reversing earlier gains after a recent rally. The stock is set to join the Nasdaq-100 on Jan. 20, with investors watching upcoming index rebalancing and Walmart’s Feb. 19 earnings report. Walmart also announced new AI shopping features with Google and plans to expand drone delivery to 150 stores in 2026.
Mastercard stock dips as Trump-backed credit card cap and swipe-fee bill keep MA in focus

Mastercard stock dips as Trump-backed credit card cap and swipe-fee bill keep MA in focus

Mastercard shares fell 0.1% to $544.29 Wednesday morning as U.S. lawmakers renewed efforts to regulate credit-card routing and cap swipe fees. A Trump-backed Senate bill would require big banks to offer more network choices for card transactions. Investors are watching Mastercard’s Jan. 29 results for signs of policy impact. Visa and American Express also traded lower.
14 January 2026
Netflix stock slips as all-cash Warner Bros bid talk swirls, with earnings days away

Netflix stock slips as all-cash Warner Bros bid talk swirls, with earnings days away

Netflix shares fell 1.6% Wednesday as investors weighed reports it may switch to an all-cash bid for Warner Bros Discovery’s studio and streaming assets, valued at $82.7 billion. Paramount Skydance, offering $108.4 billion for all of Warner Bros, escalated its challenge with a lawsuit and board nominations. Warner Bros dismissed the lawsuit as meritless. Netflix’s quarterly results are due January 20.
JP Morgan stock slips after earnings as Apple Card reserve and softer deal fees linger

JP Morgan stock slips after earnings as Apple Card reserve and softer deal fees linger

JPMorgan Chase shares fell 0.8% to $308.50 after the bank disclosed a $2.2 billion credit reserve tied to the Apple Card in its quarterly report. Net income reached $13.0 billion, or $4.63 per share, with revenue at $45.8 billion. Investment banking fees dropped 5% while markets revenue rose 17%. Executives warned a proposed 10% cap on credit card rates could hurt consumers.
Visa stock dips as Trump’s 10% credit-card rate cap gains a look in Congress

Visa stock dips as Trump’s 10% credit-card rate cap gains a look in Congress

Visa shares fell 0.3% to $326.85 Wednesday after a 4.5% drop Tuesday, as markets reacted to Donald Trump’s proposal to cap credit-card interest rates at 10%. Mastercard, American Express, and Synchrony Financial also declined. Visa announced a partnership with BVNK to enable stablecoin payouts on its Visa Direct platform. December U.S. consumer inflation rose 2.7% year-over-year, meeting forecasts.
14 January 2026
Micron stock in focus as retail traders crowd memory names and BofA lifts target to $400

Micron stock in focus as retail traders crowd memory names and BofA lifts target to $400

Micron shares fell 0.7% to $335.63 Wednesday morning after a strong rally. Bank of America raised its price target to $400, citing higher memory prices. Retail traders have ramped up bets on chipmakers, with Micron among the most traded names on Interactive Brokers. SK Hynix announced a $12.9 billion investment in advanced chip-packaging facilities.
1 313 314 315 316 317 704

Stock Market Today

  • Trinity Capital (TRIN) Faces Valuation Scrutiny Amid Share Price Decline
    March 14, 2026, 12:50 PM EDT. Trinity Capital (TRIN) shares fell 1.8% recently, with negative returns over one, three months, raising questions about its valuation. Trading at $14.42 with a price-to-earnings (P/E) ratio of 8.8x, the stock appears undervalued against its fair P/E estimate of 12x and the broader U.S. Capital Markets industry average of 22x. Despite short-term share price weakness, TRIN posted a 7.9% one-year total shareholder return and a 112.4% five-year return, reflecting long-term gains. Investors weigh these factors alongside the firm's exposure to private credit risks and potential portfolio performance challenges. The mixed P/E comparisons suggest market uncertainty about growth prospects and earnings stability in Trinity's business development and private lending operations.
Go toTop